Calliditas Therapeutics AB (publ)
CLTEF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $45,352 | $76,236 | $573,152 | $1,963,710 |
| - Cash | $563 | $23 | $20,840 | $797,278 |
| + Debt | $0 | $44 | $1,055,043 | $1,008,272 |
| Enterprise Value | $44,789 | $76,256 | $1,607,354 | $2,174,704 |
| Revenue | $0 | $0 | $0 | $559,780 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$7 | -$7 | -$7 | $506,332 |
| % Margin | -14,236.9% | – | – | 90.5% |
| EBITDA | -$128 | $26 | -$652 | -$30,445 |
| % Margin | -258,779.1% | – | – | -5.4% |
| Net Income | -$135 | $18 | -$66 | -$47,478 |
| % Margin | -273,630.5% | – | – | -8.5% |
| EPS Diluted | -0.006 | 0 | -0.004 | -0.88 |
| % Growth | – | 100% | 99.5% | – |
| Operating Cash Flow | -$206 | -$106 | -$34 | -$7,043 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$206 | -$106 | -$34 | -$7,043 |